Purpose Tirzepatide, a dual glucose-dependent insulinotropic peptide and glucagon-like
peptide 1 receptor agonist, has been approved by the US Food and Drug Administration for …

Abstract Background/Objectives Digital health interventions are increasingly utilized as an
adjunct to face-to-face counselling in the treatment of obesity. However, previous studies …

COVID-19 restrictions have dramatically reduced the active lifestyle and physical activity
(PA) levels in the whole population, a situation that can contribute to weight gain and to …

Abstract Purpose of Review To highlight that body fat depletion (the Yin paradigm) with
glucose-lowering treatments (the Yang paradigm) are associated with metabolic benefits for …

Although many individuals are able to achieve weight loss, maintaining this loss over time is
challenging. We aimed to study whether genetic predisposition to general or abdominal …

Background: Type 2 diabetes mellitus (T2DM) often leads to cardiac autonomic neuropathy
(CAN), a severe complication affecting cardiovascular health. Exercise training is a proven …

Background Patients with overweight/obesity and type 2 diabetes are encouraged to lose
weight, but not all losing weight gain better cardiovascular health, especially old adults. The …

Background and aims Diet can affect cardiovascular health by changing lipid profiles or
obesity levels. However, the association of dietary patterns reflecting lipid metabolism and …

Background It has been reported that obesity and diabetes are both risk factors for the
development of cardiovascular diseases (CVDs). However, recent articles reported that …

Background Zero-time Exercise (ZTEx), a simple strength-and stamina-enhancing physical
activity (PA) requiring no extra equipment, can potentially increase PA and fitness. This pilot …